Experimental cancer drug study halted early
NCT ID NCT04800822
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called PF-07284892, alone or with other medicines, in people with advanced solid tumors that had specific genetic changes. The goal was to find the safest dose and check for side effects. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigitte Harris Cancer Pavilion
Detroit, Michigan, 48202, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Henry Ford Medical Center - Columbus
Novi, Michigan, 48377, United States
-
Mayo Clinic
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Arizona - Phoenix
Phoenix, Arizona, 85054, United States
-
Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care
New York, New York, 10021, United States
-
Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavilion
New York, New York, 10022, United States
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START Midwest
Grand Rapids, Michigan, 49546, United States
-
Tennessee Oncology PLLC
Franklin, Tennessee, 37067, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States